These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 19121388)
41. Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying. Sansone F; Aquino RP; Del Gaudio P; Colombo P; Russo P Eur J Pharm Biopharm; 2009 May; 72(1):206-13. PubMed ID: 18996478 [TBL] [Abstract][Full Text] [Related]
42. Preparation of honokiol-loaded chitosan microparticles via spray-drying method intended for pulmonary delivery. Li X; Guo Q; Zheng X; Kong X; Shi S; Chen L; Zhao X; Wei Y; Qian Z Drug Deliv; 2009 Apr; 16(3):160-6. PubMed ID: 19514976 [TBL] [Abstract][Full Text] [Related]
43. A 'biorelevant' approach to accelerated in vitro drug release testing of a biodegradable, naltrexone implant. Iyer SS; Barr WH; Karnes HT Int J Pharm; 2007 Aug; 340(1-2):119-25. PubMed ID: 17482777 [TBL] [Abstract][Full Text] [Related]
44. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets]. Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379 [TBL] [Abstract][Full Text] [Related]
45. Abrasion of tablets during scale-up: the influence of different crushing forces in laboratory and production perforated pan coaters. Mueller R; Kleinebudde P Eur J Pharm Biopharm; 2007 Sep; 67(2):458-63. PubMed ID: 17475452 [TBL] [Abstract][Full Text] [Related]
46. Optimization of chitosan succinate and chitosan phthalate microspheres for oral delivery of insulin using response surface methodology. Ubaidulla U; Khar RK; Ahmad FJ; Tripathi P Pharm Dev Technol; 2009; 14(1):96-105. PubMed ID: 18821127 [TBL] [Abstract][Full Text] [Related]
47. A flexible drug delivery chip for the magnetically-controlled release of anti-epileptic drugs. Huang WC; Hu SH; Liu KH; Chen SY; Liu DM J Control Release; 2009 Nov; 139(3):221-8. PubMed ID: 19607866 [TBL] [Abstract][Full Text] [Related]
48. Studies of chitosan/Kollicoat SR 30D film-coated tablets for colonic drug delivery. Fan LF; He W; Chang YZ; Xiang B; Du Q; Wang F; Qin M; Cao DY Int J Pharm; 2009 Jun; 375(1-2):8-15. PubMed ID: 19457627 [TBL] [Abstract][Full Text] [Related]
49. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration. Abdelbary G; Eouani C; Prinderre P; Joachim J; Reynier J; Piccerelle P Int J Pharm; 2005 Mar; 292(1-2):29-41. PubMed ID: 15725551 [TBL] [Abstract][Full Text] [Related]
50. Intestinal patches with an immobilized solid-in-oil formulation for oral protein delivery. Toorisaka E; Watanabe K; Ono H; Hirata M; Kamiya N; Goto M Acta Biomater; 2012 Feb; 8(2):653-8. PubMed ID: 21982846 [TBL] [Abstract][Full Text] [Related]
51. The effect of chitosan on the stability and morphological parameters of tablets with Epilobium parviflorum Schreb. extract. Marczyński Z; Bodek KH Polim Med; 2007; 37(3):3-11. PubMed ID: 18251200 [TBL] [Abstract][Full Text] [Related]
52. Novel insulin thiomer nanoparticles: in vivo evaluation of an oral drug delivery system. Deutel B; Greindl M; Thaurer M; Bernkop-Schnürch A Biomacromolecules; 2008 Jan; 9(1):278-85. PubMed ID: 18159930 [TBL] [Abstract][Full Text] [Related]
53. Effects of compounding and storage conditions on stability of pergolide mesylate. Davis JL; Kirk LM; Davidson GS; Papich MG J Am Vet Med Assoc; 2009 Feb; 234(3):385-9. PubMed ID: 19210262 [TBL] [Abstract][Full Text] [Related]
54. Oral Delivery of Probiotics in Poultry Using pH-Sensitive Tablets. Jiang T; Li HS; Han GG; Singh B; Kang SK; Bok JD; Kim DD; Hong ZS; Choi YJ; Cho CS J Microbiol Biotechnol; 2017 Apr; 27(4):739-746. PubMed ID: 28081355 [TBL] [Abstract][Full Text] [Related]
55. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy. Mukherjee S; Ray S; Thakur RS Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221 [TBL] [Abstract][Full Text] [Related]
56. TARGIT technology: coated starch capsules for site-specific drug delivery into the lower gastrointestinal tract. Watts P; Smith A Expert Opin Drug Deliv; 2005 Jan; 2(1):159-67. PubMed ID: 16296742 [TBL] [Abstract][Full Text] [Related]
58. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761 [TBL] [Abstract][Full Text] [Related]
59. Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation. Khan F; Ibn Razzak SM; Khan ZR; Azad MA; Chowdhury JA; Reza S Pak J Pharm Sci; 2009 Apr; 22(2):155-61. PubMed ID: 19339225 [TBL] [Abstract][Full Text] [Related]
60. In vitro investigation of lipid implants as a controlled release system for interleukin-18. Koennings S; Garcion E; Faisant N; Menei P; Benoit JP; Goepferich A Int J Pharm; 2006 May; 314(2):145-52. PubMed ID: 16513302 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]